Note: Ingredients listed on restricted chemical lists
EC/CAS
208-534-8/9002-93-1
Name of the chemical
Octylphenolethoxylates (OPEO)
Concentration
≥0.1
General Information
Version
1.0
Revision date
2025-07-11
Product name
Rapid Extraction Buffer, Type 9
1.2.2. Uses advised against
Do not use kit components from one kit with any other kit
Manufacturer Name
Neogen Corporation
Emergency telephone
1-800-498-5743, 1-651-523-0318, 1-800-424-9300, 1-703-527-3887
Icons in SDS
Company Information
company name
Neogen Corporation
e-mail address of the competent person responsible for the Safety Data Sheet
sds@neogen.com
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH Polyethylene octylphenyl ether (9002-93-1) regulation, in accordance with Annex XIII Substance(s) not meeting the vPvB criteria of REACH Polyethylene octylphenyl ether (9002-93-1) regulation, in accordance with Annex XIII The mixture contains substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Component Substance(s) included in the list established in Polyethylene octylphenyl ether (9002-93-1) accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Not classified Adverse physicochemical, human health and environmental effects To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice. 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] No labelling applicable 2.3. Other hazards Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH Polyethylene octylphenyl ether (9002-93-1) regulation, in accordance with Annex XIII Substance(s) not meeting the vPvB criteria of REACH Polyethylene octylphenyl ether (9002-93-1) regulation, in accordance with Annex XIII The mixture contains substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Component Substance(s) included in the list established in Polyethylene octylphenyl ether (9002-93-1) accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 SECTION 3: Composition/information on ingredients 3.2. Mixtures Name Product identifier % Classification according to Regulation (EC) No. 1272/2008 [CLP] Polyethylene octylphenyl ether CAS-No.: 9002-93-1 ≥ 0.1 – < 0.5 Acute Tox. 4 (Oral), H302 substance listed on REACH Candidate List EC-No.: 208-534-8 Eye Irrit. 2, H319 substance listed on REACH Annex XIV (Polyethylene Aquatic Chronic 2, H411 glycol p-(1,1,3,3-tetramethylbutyl)phenyl ether) substance identified as having endocrine disrupting properties Full text of H- and EUH-statements: see section 16 SECTION 4: First aid measures 4.1. Description of first aid measures First-aid measures general : If you feel unwell, seek medical advice. First-aid measures after inhalation : Remove person to fresh air and keep comfortable for breathing. First-aid measures after skin contact : Wash skin with plenty of water. First-aid measures after eye contact : Rinse eyes with water as a precaution. First-aid measures after ingestion : Call a poison center or a doctor if you feel unwell. Self protection of the first-aider : First aid workers will be equipped with suitable personal protective equipment. 4.2. Most important symptoms and effects, both acute and delayed Symptoms/effects after inhalation : None under normal conditions. Symptoms/effects after skin contact : None under normal conditions. Symptoms/effects after eye contact : None under normal conditions. Symptoms/effects after ingestion : None under normal conditions. 4.3. Indication of any immediate medical attention and special treatment needed Treat symptomatically. SECTION 5: Firefighting measures 5.1. Extinguishing media Suitable extinguishing media : Water spray. Dry powder. Foam. Carbon dioxide. Unsuitable extinguishing media : Do not use a heavy water stream. 5.2. Special hazards arising from the substance or mixture Fire hazard : No fire hazard.